Dexlansoprazole Capsule, Delayed Release
Product Images NDC 72162-2239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 72162-2239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

FDA Label Image

Figure 1 (Dexlansoprazole 02)

Figure 1 (Dexlansoprazole 02)
This text appears to be a graph or chart showing plasma concentration over time for two doses (30 mg and 60 mg) of a drug called DEXLANSOPRAZOLE. The units for plasma concentration are likely ng/mL. The time is represented in hours. However, without further context or information, it is not possible to provide a more specific or useful description.*
FDA Label Image

Label (Lbl721622239)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.